| | | | |
| | SCHEDULE 13G | | Page ___ of ___ |
Item 1(a) Name of issuer: Inari Medical, Inc.
Item 1(b) Address of issuer’s principal executive offices: 6001 Oak Canyon, Suite 100, Irvine, California 92618
2(a) Name of person filing:
CVF, LLC (“CVF”)
2(b) Address or principal business office or, if none, residence:
222 N. LaSalle Street, Suite 2000, Chicago, Illinois 60601
2(c) Citizenship:
Delaware
2(d) Title of class of securities:
Common Stock, $0.001 par value per share
2(e) CUSIP No.:
45332Y109
2(a) Name of person filing:
HCC Manager LLC (“HCC”)
2(b) Address or principal business office or, if none, residence:
222 N. LaSalle Street, Suite 2000, Chicago, Illinois 60601
2(c) Citizenship:
Illinois
2(d) Title of class of securities:
Common Stock, $0.001 par value per share
2(e) CUSIP No.: 45332Y109
Item 3. | If this statement is filed pursuant to §§240.13d–1(b) or 240.13d–2(b) or (c), check whether the person filing is a: |
| | | | |
(a) | | ☐ | | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); |
| | |
(b) | | ☐ | | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); |
| | |
(c) | | ☐ | | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
| | |
(d) | | ☐ | | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8); |
| | |
(e) | | ☐ | | An investment adviser in accordance with §240.13d–1(b)(1)(ii)(E); |
| | |
(f) | | ☐ | | An employee benefit plan or endowment fund in accordance with §240.13d–1(b)(1)(ii)(F); |
| | |
(g) | | ☐ | | A parent holding company or control person in accordance with §240.13d–1(b)(1)(ii)(G); |